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Abstract
Background: Candida parapsilosis is frequently isolated from hospital environments, like air and surfaces, and
causes serious nosocomial infections. Molecular studies provided evidence of great genetic diversity within the C.
parapsilosis species complex but, despite their growing importance as pathogens, little is known about their
potential to cause disease, particularly their interactions with phagocytes. In this study, clinical and environmental
C. parapsilosis isolates, and strains of the related species C. orthopsilosis and C. metapsilosis were assayed for their
ability to induce macrophage cytotocixity and secretion of the pro-inflammatory cytokine TNF-a, to produce
pseudo-hyphae and to secrete hydrolytic enzymes.
Results: Environmental C. parapsilosis isolates caused a statistically significant (p = 0.0002) higher cell damage
compared with the clinical strains, while C. orthopsilosis and C. metapsilosis were less cytotoxic. On the other hand,
clinical isolates induced a higher TNF-a production compared with environmental strains (p < 0.0001). Whereas the
amount of TNF-a produced in response to C. orthopsilosis strains was similar to the obtained with C. parapsilosis
environmental isolates, it was lower for C. metapsilosis strains. No correlation between pseudo-hyphae formation or
proteolytic enzymes secretion and macrophage death was detected (p > 0.05). However, a positive correlation
between pseudo-hyphae formation and TNF-a secretion was observed (p = 0.0119).
Conclusions: We show that environmental C. parapsilosis strains are more resistant to phagocytic host defences
than bloodstream isolates, being potentially more deleterious in the course of infection than strains from a clinical
source. Thus, active environmental surveillance and application of strict cleaning procedures should be
implemented in order to prevent cross-infection and hospital outbreaks.
Background
Candida parapsilosis is a human commensal of epithe-
lial and mucosal tissues, also frequently isolated from
hospital environments, like air and surfaces. It is the
cause of serious nosocomial infections, being the second
most common fungal species isolated from blood in
many regions of the world [1-3]. Due to its association
with parenteral nutrition and intravascular catheters, C.
parapsilosis affects mainly critically ill patients from sur-
gical intensive care units, neonates, and cancer patients
[4-6]. Neonates are especially prone to candidemia, and
in low weight infants the estimated incidence of invasive
infections due to C. parapsilosis is 2%, reaching as
much as 10% in extreme cases [7-9].
The modes of transmission and portals of entry of
fungal nosocomial infections vary according to the
pathogen involved. Candida infections are predomi-
nantly of endogenous origin but cross-infection via
hands of health care workers or relatives, or through
devices has been shown to occur [10]. Invasive fungal
infections may be acquired in the hospital from different
sources, and numerous fungal reservoirs have been iden-
tified in hospital environment, including unfiltered air,
ventilation systems, contaminated dust during hospital
construction, carpeting, water, food, and ornamental
plants [11]. In fact, environmental exposure to C. para-
psilosis from hospital healthcare workers has been asso-
ciated with both sporadic cases and outbreaks of
invasive fungal infections in immunocompromised
patients [12,13].
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wide range of putative virulence factors to assist in their
ability to colonize host tissues, cause disease, and over-
come host defenses. Among them, secretion of hydroly-
tic enzymes such as aspartic proteinases and lipases, as
well as morphogenesis have been well studied in C. albi-
cans [14-16]. However, despite the growing importance
of the C. parapsilosis species complex, few works evalu-
ating the in vitro virulence of these species have been
performed [17-19] and little is known about the viru-
lence traits that enable them to cause disease.
Mononuclear phagocytes play an important role in
innate immunity, in the polarization of the immune
adaptive response and also in the eradication of Can-
dida sp. [20,21]. Given the critical role played by macro-
phages in balancing colonization/infection, the analysis
of their interaction with isolates belonging to the C.
parapsilosis complex is important to understand the
virulence potential of these species.
I nt h ep r e s e n tw o r k ,w ec o m p a r e dC. parapsilosis
bloodstream isolates and strains recovered from the hos-
pital setting regarding their virulence in vitro. Mononuc-
lear phagocytes were used to test the strain ability to: (i)
induce cytotocixity; (ii) activate TNF-a release; (iii) fila-
ment in vitro, both during macrophage infection and in
the presence of serum, and (iv) secrete hydrolytic
enzymes. Candida parapsilosis environmental isolates
revealed to be the most virulent to macrophage cells,
being potentially more deleterious, particularly in the
initial phases of the infection, than strains from a clini-
cal source.
Results
Candida parapsilosis interaction with macrophages
The ability of macrophages to kill C. parapsilosis blood-
stream isolates and environmental strains was deter-
mined by CFU counting after one hour co-incubation,
using six isolates of each. The average percentage of yeast
killing for the environmental isolates was 10.97 ± 2.67
while for clinical isolates it was 33.22 ± 5.25, the differ-
ence being statistically significant (p = 0.0409). The inter-
action of one clinical and one environmental isolate with
macrophages was followed for 12 hours of incubation.
Microscopic examination showed that the clinical isolate
was able to produce pseudo-hyphae and maintained that
ability in contact with macrophages (Figure 1a and 1b),
while the environmental isolate kept the yeast unicellular
morphology (Figure 1c to 1e).
The percentage of dead macrophages after co-incuba-
tion with the same two isolates, assessed by propidium
iodide (PI) staining, showed that macrophage killing did
not vary significantly in the first 8 hours of incubation,
with percentages of macrophage death similar to the
negative control (Figure 2 and 3). However, after 12
hours of infection with the clinical isolate the percentage
of macrophage killing increased to 41% (Figure 2c, 12
Figure 1 Microscopic observations of C. parapsilosis incubated with J774 macrophages. Hemacolor staining and bright field images of the
co-incubation of macrophages with the clinical isolate 972697 (a and b) and the environmental isolate CarcC (c to e), after 12 hours. Arrows
point to the different yeast morphologies in contact with macrophages.
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the environmental strain, the number of macrophages in
the slide was significantly reduced (Figure 3a, b, 12 h)
when compared with the first hours of infection, and
with the negative control (Figure 3d, 12 h) and many
yeast cells could be observed. Therefore, in this case, the
proportion of PI positive cells could not be quantified
due to the reduction of macrophage cell numbers, prob-
ably by cell lysis. Together, these observations suggested
that clinical and environmental isolates behave differ-
ently in contact with macrophages. Although unable to
filament, the environmental isolate induced macrophage
cytotoxicity and cell lysis, which is consistent with the
lower yeast killing observed previously. Following these
results, twenty-five blood isolates and twenty environ-
mental isolates were selected to test these findings, and
the studies were extended to eight C. orthopsilosis and
four C. metapsilosis strains, for comparison.
Candida parapsilosis environmental isolates are more
cytotoxic to macrophages
The release of LDH by macrophages was monitored
after 12 hours of co-incubation using all the different
strains analysed in this study (Table 1). Results showed
Figure 2 Macrophage death upon contact with the C. parapsilosis blood isolate 972697. To detect dead phagocytes, cells were incubated
with 1 μg/ml of PI and visualized at 1, 2, 4, 8, and 12 hours of infection with a magnification of 200 ×. Necrotic nuclei are presented in red.
Images were obtained using fluorescent microscopy (c), bright-field microscopy (b) and the superposition of both (a). At each time point, dead
macrophages without C. parapsilosis served as negative control (d). C. parapsilosis cell morphology in the absence of macrophages (e).
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59.2%, revealing a great variability in strain ability to
induce damage. Due to this variability the isolates were
grouped into two classes of cytotoxicity and it was
observed that the great majority of environmental
strains exhibited cytotoxicity levels between 30.1 and
60.0%, while clinical isolates were mainly in the group
presenting 1 to 30% cytotoxicity (Figure 4). Overall, the
environmental isolates induced statistically significant (p
< 0.0001) higher cell damage (average 37.6% ± 13.78)
when compared with the clinical strains (22.9 ± 10.36).
Regarding C. orthopsilosis and C. metapsilosis the
average percentage of induced cytotoxicity was 19.3% (±
6.17) and 8.8% (± 1.05), respectively.
Clinical isolates of C. parapsilosis are able to induce a
higher inflammatory response in infected macrophages
The amount of TNF-a released by infected macro-
phages was quantified as an indication of the yeast
potential to induce an inflammatory response. TNF-a
released varied from 50.51 to 809.4 pg/ml (Figure 5).
The blood isolates induced a higher TNF-a secretion
(average 557.7 ± 190.95 pg/ml) compared with the
environmental strains (average 234.6 ± 108.7 pg/ml) and
Figure 3 Macrophage death upon contact with the C. parapsilosis environmental strain CarcC. To detect dead phagocytes, cells were
incubated with 1 μg/ml of PI and visualized at 1, 2, 4, 8, and 12 hours of infection with a magnification of 200 ×. Images were obtained using
fluorescent microscopy (c), bright-field microscopy (b) and the superposition of both (a). At each time point, dead macrophages without C.
parapsilosis served as negative control (d). C. parapsilosis cell morphology in the absence of macrophages (e).
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Page 4 of 10Table 1 Species used in this study, their collection date, and origin
Species Isolate identification Geographical origin Collection date Product
Environmental C. parapsilosis IPOA1 Portugal - Hospital 1 2007 Water tap nursery 23
C. parapsilosis IPOA2 Portugal - Hospital 1 2007 Bedside table no. 4 nursery 30
C. parapsilosis IPOA3 Portugal - Hospital 1 2007 Water tap nursery 24
C. parapsilosis IPOA14 Portugal - Hospital 1 2007 Treatment room
C. parapsilosis IPOA15 Portugal - Hospital 1 2007 Door knob Patients’ WC
C. parapsilosis IPOA20 Portugal - Hospital 1 2007 Air from individual room no.5
C. parapsilosis IPOA21 Portugal - Hospital 1 2007 Water tap treatment room
C. parapsilosis IPOA22 Portugal - Hospital 1 2007 Shower Patients’ WC
C. parapsilosis IPOA23 Portugal - Hospital 1 2007 Air from nursery 24
C. parapsilosis CNR40 France 2007 Hospital environment
C. parapsilosis 494F France 2007 Hospital environment
C. parapsilosis Carc Portugal 2006 Beach sand
C. parapsilosis Avc Portugal 2006 Beach sand
C. parapsilosis Pr b Portugal 2006 Beach sand
C. parapsilosis 1144 Portugal - Hospital 2 2006 Hospital air
C. parapsilosis 1156 Portugal - Hospital 2 2006 Hospital air
C. parapsilosis 1159 Portugal - Hospital 2 2006 Hospital air
C. parapsilosis 1160 Portugal - Hospital 2 2006 Hospital air
C. parapsilosis 1182 Portugal - Hospital 2 2006 Hospital air
C. parapsilosis 1194 Portugal - Hospital 2 2006 Hospital air
Clinical C. parapsilosis 376604 Portugal - Hospital 1 2002 Blood culture
C. parapsilosis 378058 Portugal - Hospital 1 2002 Blood culture
C. parapsilosis 378690 Portugal - Hospital 1 2002 Blood culture
C. parapsilosis 433573 Portugal - Hospital 1 2003 Blood culture
C. parapsilosis 431472 Portugal - Hospital 1 2003 Blood culture
C. parapsilosis 476446 Portugal - Hospital 1 2003 Blood culture
C. parapsilosis 506858 Portugal - Hospital 1 2003 Blood culture
C. parapsilosis 522760 Portugal - Hospital 1 2004 Blood culture
C. parapsilosis 864647 Portugal - Hospital 1 2006 Blood culture
C. parapsilosis 814455 Portugal - Hospital 1 2006 Blood culture
C. parapsilosis 972697 Portugal - Hospital 1 2007 Blood culture
C. parapsilosis 20L France 2004 Blood culture
C. parapsilosis 155 France 2004 Blood culture
C. parapsilosis 202 France 2004 Blood culture
C. parapsilosis 272 France 2004 Blood culture
C. parapsilosis 465 France 2005 Blood culture
C. parapsilosis 573 France 2005 Blood culture
C. parapsilosis 648 France 2006 Blood culture
C. parapsilosis 899 France 2006 Blood culture
C. parapsilosis CAN16 Portugal - Hospital 3 2002 Blood culture
C. parapsilosis CAN159 Portugal - Hospital 3 2004 Blood culture
C. parapsilosis CAN201 Portugal - Hospital 3 2005 Blood culture
C. parapsilosis CAN270 Portugal - Hospital 3 2006 Blood culture
C. parapsilosis CAN279 Portugal - Hospital 3 2007 Blood culture
C. parapsilosis H1 USA - Blood culture
C. ortopsilosis 754 Portugal - Hospital 2 2004 Bronchial secretions
C. ortopsilosis 755 Portugal - Hospital 2 2004 Bronchial secretions
C. ortopsilosis 892 Portugal - Hospital 2 2004 Blood culture
C. ortopsilosis 894 Portugal - Hospital 2 2004 Blood culture
C. ortopsilosis 895 Portugal - Hospital 2 2004 Blood culture
C. ortopsilosis 981224 USA - Unknown
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The average amount of TNF-a production by C. orthop-
silosis strains was 204.6 ± 77.40 pg/ml, similar to C.
parapsilosis environmental isolates, whereas for C.
metapsilosis only 75.4 ± 23.84 pg/ml was detected. All
comparisons were statistically significant (p < 0.05)
except for C. orthopsilosis vs environmental C. parapsi-
losis strains.
Pseudo-hyphae formation and secretion of aspartic
proteinase and phospholipase
Virulence factors such as secretion of hydrolytic
enzymes, aspartic proteinases and/or phospholipases,
and pseudo-hyphae formation are likely to contribute to
Candida cytotoxicity. These characteristics were mea-
sured in all isolates used in this study and results are
shown in Table 2. About 60% of C. parapsilosis isolates
were able to produce pseudo-hyphae after 12 hours of
incubation. Interestingly, comparing environmental with
clinical isolates, the majority of the pseudo-hyphae pro-
ducers were the clinical ones, and this difference was
statistically significant (c
2 =4 . 6 6 4 ,p = 0.0154). Around
half of the C. orthopsilosis strains produced pseudo-
hyphae, while none of the C. metapsilosis isolates was
able to filament.
High proteinase activity was found in 36 (80.0%) C.
parapsilosis strains, being 38.8% environmental and
61.2% clinical isolates (Table 2). However, no significant
difference (c
2 = 2.250, p = 0.0688) was observed when
comparing environmental and clinical isolates. No Sap
production was observed in most of the C. orthopsilosis
and C. metapsilosis isolates (Table 2). No significant
phospholipase production was detected in the tested
isolates.
Discussion
Candida parapsilosis accounts for a significant propor-
tion of nosocomial infections, with an increasing preva-
lence in hospital settings. As with other Candida
species, invasion of C. parapsilosis can result in severe
disease, particularly in hosts with a compromised
immune system. Unlike C. albicans, the transmission
and acquisition of infection due to C. parapsilosis is
mainly exogenous and environmental strains are often
the source of infection. The main issue of this study
was, therefore, the comparison of the virulence potential
of environmental and clinical C. parapsilosis isolates.
Macrophages play an important role in the immune
response, directly by phagocytosing and killing microbial
pathogens, and indirectly by processing and presenting
antigens and secreting cytokines [22]. Although there
were variations in the intracellular killing of the different
strains, the average percentage was of about 35% for the
clinical isolates, in agreement with the results obtained
by Gácser et al. [18] for C. parapsilosis.C u r i o u s l y ,t h e s e
Table 1 Species used in this study, their collection date, and origin (Continued)
C. ortopsilosis H10 USA - Unknown
C. ortopsilosis CAN 138 Portugal - Hospital 3 2004 Blood culture
C. metapsilosis 911012 Portugal - Hospital 1 2006 Blood culture
C. metapsilosis CAN 155 Portugal - Hospital 3 2004 Blood culture
C. metapsilosis 960161 USA - Unknown
C. metapsilosis am 2006 USA - Unknown
Figure 4 Distribution of C. parapsilosis environmental and
blood isolates, according to the defined classes of cytotoxicity.
The majority of environmental isolates are included in the group
causing between 30 and 60% cytotoxicity. Cellular damage induced
by the yeast was quantified as the amount of LDH release by
macrophages after 12 hours of infection.
Figure 5 Determination of TNF-a release. Level of TNF-a release
by macrophages infected with environmental and bloodculture C.
parapsilosis isolates, and with C. orthopsilosis, and C. metapsilosis
isolates after 12 hours of infection.
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pointing to a clear difference between environmental and
clinical isolates, regarding interaction with macrophages.
A great variability in the capacity of the strains to cause
cell damage was also found, and again environmental iso-
lates induced significantly higher macrophage damage
than blood isolates, confirming a strong relationship
between the source of the isolates and their ability to
cause damage. It was also observed that C. orthopsilosis
induced a high level of macrophage damage, similar to C.
parapsilosis bloodstream isolates, while C. metapsilosis
induced the lowest cytotoxicity level. These facts agree
with previous works on reconstituted human oral epithe-
lial and epidermal tissues [19] and microglial cells [23],
showing that C. metapsilosis was less virulent compared
to C. orthopsilosis and C. parapsilosis. To correlate these
findings with the morphology, yeast strains were induced
to filament in the presence of serum and results showed
that 57.7% of the tested C. parapsilosis isolates were able
to produce pseudo-hyphae after 12 hours of incubation,
with the clinical isolates filamenting in a higher percen-
tage than the environmental strains. Curiously, this high
filamentation ability was not correlated with higher
macrophage cytotoxicity as it has been described for C.
albicans [24,25]. In our study, although C. parapsilosis
filamentation occurred right after 4 hours, differences in
macrophage death were observed only after 12 hours of
co-incubation. Incubation with the strains that did not
develop pseudo-hyphae revealed that, after 12 hours of
infection, a huge number of macrophages had disap-
peared and the yeast number was high. This observation
could be explained by the hypothesis that yeast replicate
inside macrophages and lyse them, enabling the release
of yeast into the medium, as well as LDH. Since filamen-
tation was not responsible for the death of the macro-
phages incubated with the environmental strains, maybe
other virulence factors could account for these
observations.
Secretion of hydrolytic enzymes such as aspartic pro-
teinases and phospholipases have been associated with
C.albicans virulence [14,16,26,27] and also with C. para-
psilosis virulence [15,18,28-31]. Eighty percent of the
tested C. parapsilosis strains were found to have high
proteinase activity, being the majority blood isolates. To
our knowledge, no other study compared Sap produc-
tion in clinical and environmental C. parapsilosis iso-
lates, but Dagdeviren et al. [32] observed a higher
production of acid proteinase among C. parapsilosis
blood isolates compared to non-blood isolates. From the
eight C. orthopsilosis tested only 25% were Sap produ-
cers, whereas none of the C. metapsilosis was. This is in
accordance with Lin et al. [33], who also reported differ-
ences in proteinase activity within the three major
groups of C. parapsilosis.
No correlation was observed between hydrolytic
enzymes secretion and environmental or clinical isolates,
or with cell damage (p > 0.05).
Macrophage activation induces releasing of several key
mediators, including proinflammatory cytokines such as
TNF-a, which are important for protecting the host
against disseminated candidiasis [34-36]. The amount of
TNF-a produced by macrophages infected with C. para-
psilosis isolates from bloodcultures was significantly
higher than the amount produced by macrophages
infected with environmental isolates, indicating that
clinical isolates induce a higher pro-inflammatory
response than environmental strains. The fact that a
high macrophage cell lysis occurred in the co-incuba-
tions with the environmental strains could also account
for these results. In contrast, Orsi et al. [23] reported lit-
tle or no TNF-a production in the co-incubations of
strains of the C. parapsilosis complex with microglial
cells. This discrepancy may result from the fact that the
6-hour incubation time used in their study was insuffi-
cient to trigger cell response. Our results showed a posi-
tive correlation between filamentation and TNF-a
release (p = 0.0119) for C. parapsilosis. Candida orthop-
silosis strains induced TNF-a levels similar to the clini-
cal isolates, whereas C. metapsilosis isolates induced the
production of lower amounts, which is in agreement
with Gácser et al. [19] who showed that C. metapsilosis
appears as the less virulent of the three species of the C.
parapsilosis complex. Nevertheless, recent literature
indicates that C. metapsilosis can be retrospectively
identified at a frequency similar to C. orthopsilosis and
from virtually all body sites [37,38]. In addition, a meta-
genomic study has found C. metapsilosis sequences in
the oral cavity of healthy carriers, suggesting the possibi-
lity of oral commensalism for this species [39].
Conclusions
Overall, this report evidences for the first time that
environmental and clinical C. parapsilosis isolates
behave differently in contact with macrophages,
Table 2 Pseudo-hyphae and secreted aspartyl proteinase
(sap) production
Isolates Pseudo-hyphae production Sap production
Yes No High Low
C. parapsilosis
Environment 8 12 14 6
Bloodcultures 18 7 22 3
C. orthopsilosis 35 2 6
C. metapsilosis 04 0 4
Total no. of strains 29 28 38 19
Study of 45 environmental and clinical Candida parapsilosis isolates, 8 C.
orthopsilosis and 4 C. metapsilosis strains.
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lular damage and seem to be more prone to resist to
macrophage killing. Since nosocomial fungal infections
progress rapidly, and C. parapsilosis is frequently iso-
lated from the hospital settings, there is a critical need
for more efforts toward prevention, early diagnosis, and
effective treatment of these infections. Among the pre-
ventive measures the environmental surveillance and
strict application of cleaning procedures are of major
importance to prevent the onset of hospital outbreaks.
Methods
Candida isolates and preparation of cell suspensions
Forty-five C. parapsilosis isolates, eight C. orthopsilosis iso-
lates, and four C. metapsilosis isolates were used in this
study (Table 1). Twenty-five of the C. parapsilosis isolates
were from bloodstream infections, and 20 were obtained
from the hospital environment, including bedside tables,
doors knobs, surfaces, and air. The identity of the isolates
was confirmed at the species level by locus specific ampli-
fication [40] or by sequencing the ribosomal ITS region
[41]. Yeast cells were grown overnight at 37°C in YEPD
medium (2% glucose, 1% bacto peptone, and 2% yeast
extract), recovered by centrifugation, washed in sterile PBS
buffer, and a suspension of 2 × 10
7cells/ml was prepared
in Dulbecco’s Modified Eagle’sM e d i u m( D M E M ) .
Macrophage culture and determination of candidacidal
activity
The murine macrophage-like cell line J774A.1 (Ameri-
can Type Culture Center number TIB 67Ralph and
Nakoinz, 1975) was cultured in complete DMEM sup-
plemented with 10% heat-inactivated fetal calf serum
(FBS), at 37°C in a 5% CO2 atmosphere. After confluent
growth, macrophage cells were recovered, washed, and
re-suspended in DMEM to a final concentration of 4 ×
10
5cells/ml. Yeast killing was assessed by using a multi-
plicity of infection (MOI) of 1:10 in 24 well tissue-cul-
ture plates (Orange) for 60 minutes, at 37°C in a 5%
CO2 atmosphere. After incubation macrophage cells
were lysed with 800 μl of cold water and wells scrapped
to ensure removal of all the yeast cells. Lysates were
serially diluted and plated on YEPD agar to determine
the percentage of viable yeast cells. Controls consisted
of yeast cells grown in the same conditions but without
macrophages. Candidacidal activity (%) was calculated
using the following formula: [(CFU of control well -
CFU of test well)/CFU of control well] × 100. Each
strain was tested in triplicate.
Analysis of C. parapsilosis morphology during
macrophage infection
Yeast cell morphology in contact with macrophages was
evaluated by co-incubating the macrophage cell line
with Candida cells, as described above. Macrophage
cells were seeded into 24 well tissue-culture plates con-
taining a plastic coverslip in each well (Nunc, Rochester,
USA) to allow macrophage adherence. After 1, 4, 8, 10
and 12 hours of co-incubation coverslips were removed,
fixed with 10% formol on ethanol, and Hemacolor
(Merck, New Jersey, EUA) stained. Different fields were
analyzed under a Leica DM5000B light microscope and
images captured with a Leica DFC350FX camera.
Macrophage death assessment
Kinetic of macrophage death was assessed by incubating
macrophages with C. parapsilosis at a MOI of 1:10 as
previously described. Macrophage death was assayed by
determining the percentage of cells with plasma mem-
branes permeable to propidium iodide (PI) after 1, 2, 3,
4, 6, 8, 10 and 12 hours of co-incubation. Cells on the
coverslips were stained with 1 μg/ml PI at room tem-
perature for 10 min in the dark, and observed using a
Leica DM5000B fluorescence microscope. At each time
point, images were taken and approximately 1000 cells
were counted in independent fields. The percentage of
macrophage cells permeable to PI was calculated as
described by Shin et al. [24].
Lactate dehydrogenase (LDH) measurement
The release of LDH from cells into the medium was
monitored as a measure of cell damage. LDH released
in the medium from macrophage cultures (negative con-
trol) and from macrophages co-incubated with C. para-
psilosis, C. orthopsilosis and C. metapsilosis was
measured after 12 h incubation by using the Cytotoxi-
city Detection Kit PLUS (LDH) (Roche Diagnostics Cor-
poration, Indianapolis, USA), according to the
manufacturer’s instructions.
Cytokine measurement
TNF-a production by macrophages infected with the
strains in study was measured using the Mouse TNFa
ELISA ReadySETGoKit (eBioscience, San Diego, CA,
USA), according to the manufacturer’s instructions.
Secreted aspartic proteinase and phospholipase
production
The production of secreted aspartic proteinases (Sap)
and phospholipases by isolates of C. parapsilosis, C.
orthopsilosis and C. metapsilosis was determined as pre-
viously described [42]. One C. albicans producer strain
(SC5314) was added as a positive control.
Filamentation assay
Filamentation was assessed by seeding 200 μl of the pre-
pared cell suspensions into 24 well tissue-culture plates
(Orange), and incubating at 37°C in a 5% CO2
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was then smeared onto a glass slide and images were
taken with a Leica DM5000B light microscope.
Statistical analysis
Unless otherwise stated, results shown are the mean of
three independent experiments ± SD. Statistical signifi-
cance of results was determined by the T student test or
the c
2-test. Results were considered statistically signifi-
cant when two-tailed p values were less than 0.05. All
calculations were performed with GraphPad Prism 5
software.
Acknowledgements
This research was supported by FEDER funds through the Operational
Programme COMPETE and national funds through Fundação para a Ciência
e Tecnologia (FCT), in the scope of project PEst-C/BIA/UI4050/2011. Raquel
Sabino received a fellowship from FCT (contract BD/22100/2005). We are
indebted to Frédéric Grenouillet, Guillermo Garcia-Effron, Zélia Videira and
Maria da Luz Martins for kindly providing part of the isolates used in this
study.
Author details
1CBMA - Centre of Molecular and Environmental Biology, Department of
Biology, University of Minho, Braga, Portugal.
2Laboratório de Micologia,
Departamento de Doenças Infecciosas, Instituto Nacional de Saúde Dr.
Ricardo Jorge, Lisboa, Portugal.
Authors’ contributions
PS and CP conceived and designed the study. RS, PS, and CC performed the
experiments; RS, PS, LR, and CP analyzed the data; RS, PS and CP wrote the
manuscript. All authors have read and approved the final version of the
manuscript
Received: 18 February 2011 Accepted: 8 August 2011
Published: 8 August 2011
References
1. Moran GP, Sullivan DJ, Coleman DC: Emergence of non Candida albicans
Candida species as pathogens. In Candida and Candidiasis. Edited by:
Calderone RA. Washington DC: ASM Press; 2002:341-348.
2. Almirante B, Rodriguez D, Cuenca-Estrella M, Almela M, Sanchez F, Ayats J,
Alonso-Tarres C, Rodriguez-Tudela JL, Pahissa A, the Barcelona Candidemia
Project Study Group: Epidemiology, risk factors and prognosis of Candida
parapsilosis bloodstream infections: case-control population-based
surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J
Clin Microbiol 2006, 44:1681-1685.
3. Costa-de-Oliveira S, Pina-Vaz C, Mendonça D, Rodrigues AG: A first
Portuguese epidemiological survey of fungaemia in a university hospital.
Eur J Clin Microbiol Infect Dis 2008, 27:365-374.
4. Trofa D, Gácser A, Nosanchuk JD: Candida parapsilosis, an emerging
fungal pathogen. Clin Microbiol Rev 2008, 21:606-625.
5. van Asbeck EC, Clemons KV, Stevens DA: Candida parapsilosis: a review of
its epidemiology, pathogenesis, clinical aspects, typing, and
antimicrobial susceptibility. Crit Rev Microbiol 2009, 35:283-309.
6. Sabino R, Veríssimo C, Brandão J, Alves C, Parada H, Rosado L, Paixão E,
Videira Z, Tendeiro T, Sampaio P, Pais C: Epidemiology of candidemia in
oncology patients: a 6-year survey in a Portuguese central hospital. Med
Mycol 2010, 48:346-54.
7. Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J,
Blumberg HM, Patterson JE, Rinaldi M, Edwards JE, Wenzel RP, Jarvis W: Risk
factors for candidemia in neonatal intensive care unit patients. The
National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J
2000, 19:319-24.
8. Karlowicz MG, Rowen JL, Barnes-Eley ML, Burke BL, Lawson ML, Bendel CM,
Shattuck KE, Horgan M, Albritton WL: The role of birth weight and
gestational age in distinguishing extremely low birth weight infants at
high risk of developing candidemia from infants at low risk: a
multicenter study. Pediatr Res 2002, 51:301A.
9. Clerihew L, Lamagni TL, Brocklehurst P, McGuire W: Candida parapsilosis
infection in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed
2007, 92:F127-F129.
10. Muňoz P, Burillo A, Pouza E: Environmental surveillance and other control
measures in the prevention of nosocomial fungal infections. Clin
Microbiol Infect 2001, 7:38-45.
11. Sautour M, Dalle F, Olivieri C, L’ollivier C, Enderlin E, Salome E, Chovelon I,
Vagner O, Sixt N, Fricker-Pap V, Aho S, Fontaneau O, Cachia C, Bonnin A: A
prospective survey of air and surface fungal contamination in a medical
mycology laboratory at a tertiary care university hospital. Am J Infect
Control 2009, 37:189-194.
12. Barchesi F, Caggiano G, Falconi Di Francesco L, Montagna MT, Barbuti S,
Scalise G: Outbreak of fungemia due to Candida parapsilosis in a
pediatric oncologic unit. Diagn microbial Infect Dis 2004, 49:269-271.
13. van Asbeck EC, Huang Y-C, Markham AN, Clemons KV, Stevens DA: Candida
parapsilosis fungemia in neonates: genotyping results suggest
healthcare workers hands as source, and review of published studies.
Mycophatologia 2007, 164:287-293.
14. Hube B, Stehr F, Bossenz M, Mazur A, Kretschmar M, Schäfer W: Secreted
lipases of Candida albicans: cloning, characterisation and expression
analysis of a new gene family with at least ten members. Arch Microbiol
2000, 174:362-374.
15. Khun DM, Mikherjee PK, Clark TA, Pujol C, Chandra J, Hajjeh RA,
Warnock DW, Soil DR, Ghannoum MA: Candida parapsilosis
characterization in an outbreak setting. Emerg Infect Dis 2004,
10:1074-1081.
16. Bramono K, amazaki M, Tsuboi R, Ogawa H: Comparison of proteinase,
lipase and alpha-glucosidase activities from the clinical isolates of
Candida species. Jpn J Infec Dis 2006, 59:73-76.
17. Owaki T, Meneshian A, Maemura K, Takao S, Wang D, Fuh KC, Bulkley GB,
Klein AS: Endothelial cells potentiate phagocytic killing by macrophages
via platelet-activating factor release. Am J Physiol Heart Circ Physiol 2000,
278:H269-H276.
18. Gácser A, Trofa D, Schäfer W, Nosanchuk JD: Targeted gene deletion in
Candida parapsilosis demonstrates the role of secreted lipase in
virulence. J Clin Invest 2007, 117:3049-3058.
19. Gácser A, Schafer W, Nosanchuk JS, Salomon S, Nosanchuk JD: Virulence of
Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in
reconstituted human tissue models. Fungal Genet Biol 2007, 44:1336-1341.
20. Maródi L, Schreiber S, Anderson DC, MacDermott RP, Korchak HM,
Johnston RB Jr: Enhancement of macrophage candidacidal activity by
interferon-y - increased phagocytosis, killing, and calcium signal
mediated by a decreased number of mannose receptors. J Clin Invest
1993, 91:2596-2601.
21. Camargo MR, Venturini J, Vilani-Moreno FR, Arruda MSP: Modulation of
macrophage cytokine profiles during solid tumor progression:
susceptibility to Candida albicans infection. BMC Infectious Diseases 2009,
9:98-106.
22. Lorenz MC, Fink GR: Life and death in a macrophage: role of the
glyoxylate cycle in virulence. Eukaryot Cell 2002, 1:657-662.
23. Orsi CF, Colombari B, Blasi E: Candida metapsilosis as the least virulent
member of the C. parapsilosis complex. Med Mycol 2010, 48:1024-1033.
24. Shin YK, Kim KY, Paik YK: Alterations of protein expression in
macrophages in response to Candida albicans infection. Mol Cells 2005,
20:271-279.
25. Tavanti A, Campa D, Bertozzi A, Pardini G, Naglik JR, Barale R, Senesi S:
Candida albicans isolates with different genomic backgrounds display a
differential response to macrophage infection. Microbes Infect 2006,
8:791-800.
26. Stehr F, Gácser A, Kretschmar M, Mähnss B, Neuber K, Hube B, Schäfer W:
Expression analysis of the Candida albicans lipase gene family during
experimental infections and in patient samples. FEMS Yeast Res 2004,
4:401-408.
27. Schaller M, Borelli C, Korting HC, Hube B: Hydrolytic enzymes as virulence
factors of Candida albicans. Mycoses 2005, 48:365-377.
28. De Bernardis F, Mondello F, San Millán R, Pontón J, Cassone A: Biotyping
and virulence properties of skin isolates of Candida parapsilosis. J Clin
Microbiol 1999, 37:3481-3486.
Sabino et al. BMC Microbiology 2011, 11:180
http://www.biomedcentral.com/1471-2180/11/180
Page 9 of 1029. Pichová I, Pavlicková L, Dostál J, Dolejsí E, Hrusková-Heidingsfeldová O,
Weber J, Ruml T, Soucek M: Secreted aspartic proteases of Candida
albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae.
Eur J Biochem 2001, 268:2669-2677.
30. Khun D, Chandra J, Mukherjee PK, Ghannoum MA: Comparison of biofilms
formed by Candida albicans and Candida parapsilosis on bioprosthetic
surfaces. Infect Immun 2002, 70:878-888.
31. Ozkan S, Kaynak F, Kalkanci A, Abbasoglu U, Kustimur S: Slime production
and proteinase activity of Candida species isolated from blood samples
and the comparison of these activities with minimum inhibitory
concentration values of antifungal agents. Mem Inst Oswaldo Cruz 2005,
100:319-324.
32. Dagdeviren M, Cerikcioglu N, Karavus M: Acid proteinase, phospholipase,
and adherence properties of Candida parapsilosis strains isolated fron
clinical specimens of hospitalized patients. Mycoses 2005, 48:321-326.
33. Lin DM, Wu LC, Rinaldi MG, Lehmann PF: Three distinct genotypes within
Candida parapsilosis from clinical sources. J Clin Microbiol 1995,
33:1815-1821.
34. Levitz SM: Interactions of Toll-like receptors with fungi. Microb Infect 2004,
6:1351-1355.
35. Romani L: Immunity to fungal infections. Nat Rev Immunol 2004, 4:11-24.
36. Zelante T, Montagnoli C, Bozza S, Gaziano R, Bellocchio S, Bonifazi P,
Moretti S, Fallarino F, Puccetti P, Romani L: Receptors and pathways in
innate antifungal immunity: the implication for tolerance and immunity
to fungi. Adv Exp Med Biol 2007, 590:209-221.
37. Kocsubé S, Tóth M, Vágvölgyi C, Dóczi I, Pesti M, Pócsi I, Szabó J, Varga J:
Occurrence and genetic variability of Candida parapsilosis sensu lato in
Hungary. J Med Microbiol 2007, 56(Pt 2):190-5.
38. Hensgens LA, Tavanti A, Mogavero S, Ghelardi E, Senesi S: AFLP
genotyping of Candida metapsilosis clinical isolates: Evidence for
recombination. Fungal Genet Biol 2009, 46(10):750-758.
39. Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A,
Gillevet PM: Characterization of the Oral Fungal Microbiome
(Mycobiome) in Healthy Individuals. PLoS Pathog 2010, 6(1):e1000713.
40. Sabino R, Sampaio P, Rosado L, Stevens DA, Clemons KV, Pais C: New
polymorphic microsatellite markers able to distinguish among. Candida
parapsilosis senso stricto isolates. J Clin Microbiol 2010, 48:1677-1682.
41. Sampaio JP, Gadanho M, Santos M, Duarte FL, Pais C, Fonseca A, Fell JW:
Polyphasic taxonomy of the basidiomycetous yeast genus
Rhodosporidium: Rhodosporidium kratochvilovae and related anamorphic
species. Int J Syst Evol Microbiol 2001, 51:687-697.
42. Al-Abeid H, Abu-Elteen K, Elkarmi A, Hamad M: Isolation and
characterization of Candida spp. in Jordanian cancer patients:
prevalence, pathogenic determinants and antifungal sensitivity. Jpn J
Infect Dis 2004, 57:279-284.
doi:10.1186/1471-2180-11-180
Cite this article as: Sabino et al.: Isolates from hospital environments are
the most virulent of the Candida parapsilosis complex. BMC Microbiology
2011 11:180.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sabino et al. BMC Microbiology 2011, 11:180
http://www.biomedcentral.com/1471-2180/11/180
Page 10 of 10